February 2023

UROLOGY

TREATMENT PROTOCOL FOR INCIDENTAL PROSTATE CANCER AFTER HOLEP

Episode Summary

Amy E. Krambeck, MD, has diagnosed prostate cancer in nearly 13% of her patients who underwent holmium laser enucleation of the prostate (HoLEP) for benign prostatic hyperplasia in the past year. In a recent episode of the Better Edge podcast, she and Ashley E. Ross, MD, PhD, discuss the active surveillance protocol they developed for managing incidental prostate cancer after HoLEP.
Amy E. Krambeck, MD, chief of the Division of Endourology and Stone Disease and professor of Urology at Northwestern Medicine.
Ashley E. Ross, MD, PhD, associate professor of Urology at Northwestern Medicine.

Refer a Patient

Northwestern Medicine welcomes the opportunity to partner with you in caring for your patients. ​

You May Also Like